127 related articles for article (PubMed ID: 3021068)
1. [A phase II study of UFT in non-small cell lung cancer].
Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068
[TBL] [Abstract][Full Text] [Related]
2. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H
Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of UFT on prostatic cancer].
Naito K; Hisazumi H; Misaki T; Shimada K; Miyazaki K; Kosaka S; Miyagi T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1440-4. PubMed ID: 3925886
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of UFT for head and neck cancer].
Inuyama Y; Takeda C; Miyake H; Fujii M; Tanaka J; Hirokawa T; Ooyama W; Horiuchi M; Uchida M; Kaneko S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):479-84. PubMed ID: 3923939
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer].
Takanashi N; Hara N; Ichinose Y; Asoh H; Yano T; Yokoyama H; Miura T; Matsuoka Y; Tayama K; Ohta M
Gan To Kagaku Ryoho; 1993 May; 20(7):921-7. PubMed ID: 8387761
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
10. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
11. Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer.
Kanaji N; Bandoh S; Ishida T
South Med J; 2007 Oct; 100(10):1056-7. PubMed ID: 17943058
[No Abstract] [Full Text] [Related]
12. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
[TBL] [Abstract][Full Text] [Related]
13. [Report on nationwide pooled data and cohort investigation in UFT phase II study].
Ota K; Taguchi T; Kimura K
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2749-57. PubMed ID: 3115185
[TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer].
Seike M; Andoh M; Hasegawa K; Sakonji M; Tsuboi E
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1539-42. PubMed ID: 9725046
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Ikeda M; Okusaka T; Ueno H; Morizane C; Furuse J; Ishii H
Jpn J Clin Oncol; 2005 Aug; 35(8):439-43. PubMed ID: 16024530
[TBL] [Abstract][Full Text] [Related]
16. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
Ichinose Y; Yoshimori K; Sakai H; Nakai Y; Sugiura T; Kawahara M; Niitani H
Clin Cancer Res; 2004 Dec; 10(23):7860-4. PubMed ID: 15585618
[TBL] [Abstract][Full Text] [Related]
17. [Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group].
Futatsuki K; Komita T; Kamano T; Watanabe H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1274-80. PubMed ID: 3107478
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
19. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
Yano T; Koga T; Nomiyama H; Hidaka H
Gan To Kagaku Ryoho; 2003 Jul; 30(7):959-62. PubMed ID: 12894710
[TBL] [Abstract][Full Text] [Related]
20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]